Nanjing Sinolife United Co (HKSE:03332) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03332 Nanjing Sinolife United Co Ltd HKSE:03332
57 GF Score
Price HK$0.12
GF Value HK$0.57
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Nanjing Sinolife United Co FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:03332
57GF Score
Nanjing Sinolife United Co Ltd HKSE:03332
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanjing Sinolife United Co (HKSE:03332) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing Sinolife United Co stock appears to be undervalued. The current stock price of HK$0.12 is trading 78.9% below its estimated GF Value™ of HK$0.57. GuruFocus considers Nanjing Sinolife United Co to be Possible Value Trap.

Key valuation signals for HKSE:03332:

  • FFO:
  • GF Value™: HK$0.57 vs. price of HK$0.12 (78.9% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the HKSE:03332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nanjing Sinolife United Co Business Description

Address 3 Qingma Road, 4th Floor, Building 3, Qixia District, Jiangsu Province, Nanjing, CHN
Nanjing Sinolife United Co Ltd is a company based in China, predominantly engaged in producing and selling nutritional supplements and the trading of packaged health food products. Its product offerings include Zhongsheng Coenzyme capsules, Guishi Weisi capsules, and Green Zhi capsules, among others. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from New Zealand, Australia, Vietnam, and Other countries. The Group operates has one reportable segment which is the manufacture and sale of nutritional supplements and the sale of packaged health food products in the People's Republic of China (the PRC), Australia and New Zealand.
57GF Score

Get the complete analysis for HKSE:03332

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.12
Price
HK$0.57
GF Value